The epidermal growth factor receptor is involved in angiotensin II but not aldosterone/salt-induced cardiac remodelling.
Experimental and clinical studies have shown that aldosterone/mineralocorticoid receptor (MR) activation has deleterious effects in the cardiovascular system; however, the signalling pathways involved in the pathophysiological effects of aldosterone/MR in vivo are not fully understood. Several in vi...
Guardado en:
Autores principales: | Smail Messaoudi, An Di Zhang, Violaine Griol-Charhbili, Brigitte Escoubet, Junichi Sadoshima, Nicolette Farman, Frederic Jaisser |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b89b461687e94da88897642bde4e2bc2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cardiomyopathy and response to enzyme replacement therapy in a male mouse model for Fabry disease.
por: Aurelie Nguyen Dinh Cat, et al.
Publicado: (2012) -
The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Eliecer Coto, et al.
Publicado: (2021) -
Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease
por: Ewa Szczepanska-Sadowska, et al.
Publicado: (2021) -
New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
por: Miklós Fagyas, et al.
Publicado: (2014) -
COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
por: Susanne Rysz, et al.
Publicado: (2021)